Additionally, S&P downgraded its rating on Lahey Health System’s Winchester (Mass.) Hospital’s series 2010H bonds to “A-” from “A,” affecting $69 million of debt.
“The downgrade reflects material financial underperformance year to date and LHS’ limited balance sheet strength, which does not provide sufficient flexibility to offset its weak earnings during an expected multi-year turnaround effort,” said Cynthia Keller, an S&P Global Ratings analyst.
The outlook is stable, reflecting S&P’s expectation that the health system’s enterprise strengths will help improve its financial performance. Additionally, the stable outlook reflects LHS’ adequate debt service coverage and unrestricted reserves.
More articles on healthcare finance:
UPMC to spend $900M on capital projects in 2018
Osawatomie State Hospital is one step closer to recertification, officials say
Alabama county to vote on 1 cent sales tax increase to fund new rural hospital
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
